Impact of induction chemotherapy with intermediate-dosed cytarabine and subsequent allogeneic stem cell transplantation on the outcome of high-risk acute myeloid leukemia

CONCLUSION: S-AML and t-AML patients receiving induction chemotherapy with intermediate-dosed cytarabine showed satisfactory response rate and consolidation therapy with allo-HSCT after full or reduced-intensity conditioning further improved survival in these patients with similar outcome as reported for CPX-351.PMID:34297206 | DOI:10.1007/s00432-021-03733-0

Source: Clin Med Res - July 23, 2021 Category: Research Authors: Maximilian Fleischmann Ulf Schnetzke Jochen J Frietsch Herbert G Sayer Karin Schrenk Jakob Hammersen Anita Glaser Inken Hilgendorf Andreas Hochhaus Sebastian Scholl Source Type: research